Quantifying the population-level impact of expanded antibiotic treatment for cholera outbreak management is drawing significant interest across the industry.
Author summary Cholera remains a dangerous infectious disease in many parts of the world, with more deaths occurring in more countries in recent years. Most people recover from cholera with simple rehydration. For high-risk and severe cases, antibiotics are used to clear the infection faster. Without antibiotics, people can continue to shed cholera bacteria even after they feel better. Antibiotics stop this bacterial shedding, which decreases how much bacteria is spreading in the community. However, the more antibiotics are used, the greater the likelihood that cholera develops antibiotic resistance, which would make antibiotics no longer an effective treatment. In this study, we use a mathematical model to test two antibiotic prescribing scenarios: a) the current guidelines of antibiotics only for high-risk/severe patients, and b) prescribing antibiotics to more cholera patients, with the idea that this will lead to less spreading of cholera and fewer cases overall. We show treating more types of patients (severely and moderately ill) with antibiotics can lead to smaller outbreaks and fewer doses of antibiotics prescribed under certain outbreak conditions. We also show which parts of the model are most important, and highlight areas that need more scientific research before we can be confident in our results.
Experts suggest this could influence future trends and innovation in the sector.
More updates are expected as the story develops.
Source: Original →